EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stereochemical Modulation of Palladacyclopentadienyl Complexes Bearing Diphosphine Ligands: A Key to Enhanced DNA Interaction and Anticancer Activity

Stefania Mautone, Martina Scianna, Isabella Caligiuri, Laura Orian, Pablo Nogara, Nicola Demitri, Flavio Rizzolio, Thomas Scattolin

European Journal of Inorganic Chemistry · 04.06.2026 · 29 (16)

DOI: 10.1002/ejic.70192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Inorganic Chemistry, online erschienen am 26.03.2026. Verfasst von Stefania Mautone und 7 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Palladacyclopentadienyl complexes represent a uniquely stable and structurally rigid class of organopalladium compounds with significant potential for anticancer drug development. Here, we report the first systematic exploration of palladacyclopentadienyl complexes supported by a diverse set of achiral and chiral diphosphine ligands, including DPPF, DPPE, DPPP, DPPBz, DPEPhos, Xantphos, BINAP, and Chiraphos. All complexes were obtained in high yields and fully characterized, confirming bidentate coordination and preservation of the rigid palladacyclopentadienyl framework. Biological evaluation against cisplatin‐sensitive, cisplatin‐resistant, and high‐grade serous ovarian cancer cell lines revealed that complexes bearing DPPF and DPPBz exhibit sub‐micromolar cytotoxicity combined with marked selectivity for cancer cells over non‐tumoral fibroblasts, outperforming cisplatin and carboplatin. Notably, pronounced differences in activity were observed between enantiomeric BINAP‐ and Chiraphos‐based complexes, representing a rare example of strong chirality‐dependent cytotoxicity in metal‐based agents. Molecular docking analyses were used to rationalize the observed trends, correlating cytotoxicity with the number and nature of predicted non‐covalent interactions formed with DNA. These results highlight palladacyclopentadienyl–diphosphine complexes as a highly tunable platform for anticancer drug design and identify DPPF‐ and DPPBz‐based derivatives as promising lead compounds for further preclinical evaluation.

Zitieren

APA

Mautone, S., Scianna, M., Caligiuri, I., Orian, L., Nogara, P., Demitri, N., Rizzolio, F., & Scattolin, T. (2026). Stereochemical Modulation of Palladacyclopentadienyl Complexes Bearing Diphosphine Ligands: A Key to Enhanced DNA Interaction and Anticancer Activity. European Journal of Inorganic Chemistry, 29(16). https://doi.org/10.1002/ejic.70192

Vancouver

Mautone S, Scianna M, Caligiuri I, Orian L, Nogara P, Demitri N, et al. Stereochemical Modulation of Palladacyclopentadienyl Complexes Bearing Diphosphine Ligands: A Key to Enhanced DNA Interaction and Anticancer Activity. European Journal of Inorganic Chemistry. 2026;29(16). doi:10.1002/ejic.70192

BibTeX
@article{Mautone2026,
  author = {Mautone, Stefania and Scianna, Martina and Caligiuri, Isabella and Orian, Laura and Nogara, Pablo and Demitri, Nicola and Rizzolio, Flavio and Scattolin, Thomas},
  title = {Stereochemical Modulation of Palladacyclopentadienyl Complexes Bearing Diphosphine Ligands: A Key to Enhanced DNA Interaction and Anticancer Activity},
  journal = {European Journal of Inorganic Chemistry},
  year = {2026},
  volume = {29},
  number = {16},
  doi = {10.1002/ejic.70192}
}
Kostenlos starten →